HIGHLIGHTS
- who: A Novel Five-Gene Signature and collaborators from the Chongqing Key Laboratory of Translational, Research for Metastasis and Individualized Treatment, Chongqing University Hospital, Chongqing, China have published the research: A Novel Five-Gene Signature Related to Clinical Outcome and Immune Microenvironment in Breast Cancer, in the Journal: (JOURNAL)
- what: The authors identified a novel five-gene signature for patients with BC. A study was conducted to determine the correlations between the risk score model and the presence of immune cells. The authors analyzed BC somatic mutation data from the TCGA database, and found that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.